Noveris Health Sciences Inc. is trading at CA$1.53 (+5.52%) as the stock shows signs of recovery following a period of significant price swings.

  • The upward move follows a volatile stretch that included a 14.2% decline to CA$1.45 on June 19, 2026.
  • No clear company-specific catalyst has been identified, suggesting the price action may reflect small-cap volatility and investor positioning after recent weakness.
  • Broader market conditions remain mixed, contributing to the stock's continued fluctuations in the absence of fundamental news.